Ginsenoside Rh1
Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.
Product Specifications
CAS Number
63223-86-9
Product Name Alternative
Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1
UNSPSC
12352005
Hazard Statement
H302
Target
Endogenous Metabolite; Interleukin Related; PPAR; TNF Receptor
Type
Natural Products
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Ginsenoside-Rh1.html
Purity
98.72
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@]([C@@]12C)(C[C@H](O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)[C@@]4([H])C5(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC2)([H])[C@]4(CC[C@@H]5O)C
Molecular Formula
C36H62O9
Molecular Weight
638.87
Precautions
H302
References & Citations
[1]Gu W, et al. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36 (1) :102-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
IL-1; IL-6; PPARγ; TNFRSF5/CD40
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881657-100 1x 100 µL
CD1a / HTA1 (Mature Langerhans Cells Marker), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![Buccutite™ FOL, maleimide [FOLM]](https://cdn.genprice.uk/products/271/7363548/imageurl/5356-aat.webp)
BNC471603-100 1x 100 µL
CD1c (CD1C/1603), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040967-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (MUC1/967), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942353-500 1x 500 µL
Calcineurin A / PPP3CA (CALNA/2353), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 